Biochemical and immunologic correlates of clinical response in a combination trial of the GM-CSF-gene transduced allogeneic prostate cancer immunotherapy and ipilimumab in patients with metastatic hormone-refractory prostate cancer (mHRPC) (Q114738429)
scientific article published on 06 March 2020
Language:
(P31) (Q13442814)
(P304) 5120-5120
(P407) (Q1860)
(P433) 18_suppl
(P478) 25
(P577) Friday, March 6, 2020
(P1433) (Q400292)
(P1476) "Biochemical and immunologic correlates of clinical response in a combination trial of the GM-CSF-gene transduced allogeneic prostate cancer immunotherapy and ipilimumab in patients with metastatic hormone-refractory prostate cancer (mHRPC)" (language: en)
(P2093) W. R. Gerritsen
A. J. van den Eertwegh
T. D. de Gruijl
G. Giaccone
R. J. Scheper
N. Sacks
T. Harding
I. Lowy
E. Stankevich
K. Hege
other details
description scientific article published on 06 March 2020

External Links